Ultragenyx Pharmaceutical Inc. (RARE) Form 10-Q Quarterly Reports
Ultragenyx Pharmaceutical Inc. (RARE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RARE
CIK: 1515673
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerRaymond Minehan
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-08 | 8-K | 0001193125-26-421079 | View SEC Doc Filr Page |
| 8-K | 2026-10-07 | 2026-10-06 | 8-K | 0001193125-26-416251 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-17 | 8-K | 0001515673-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-15 | 4 | 0001193125-26-392233 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009497 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-03 | 4 | 0001193125-26-384878 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-02 | 8-K | 0001193125-26-380165 | View SEC Doc Filr Page |
| 8-K | 2026-08-19 | 2026-08-19 | 8-K | 0001193125-26-357185 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001493215-26-000161 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001167557-26-000169 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-07 | 8-K | 0001193125-26-343525 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000549 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-333233 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-332802 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | 4 | 0001193125-26-332547 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-03 | 4 | 0001193125-26-332536 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007510 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0002100121-26-001001 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001487 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-30 | — | SCHEDULE 13G/A Filing | 0002012383-26-003116 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296128 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001950047-26-006703 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | 4 | 0001796536-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-15 | 4 | 0001677455-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001950047-26-006115 | View SEC Doc Filr Page |